Andrew Mansfield Head of Flow Chemistry, Syrris
The researchers at the Department of Pharmacy (University of Bari, Italy) demonstrated handling of a borane solution safely and the switch to the use of 2-MeTHF as a greener alternative to traditional solvents. Another real benefit of using flow technology was that it allowed for a reduction of the amount of the chiral catalyst and avoided the use of an additive such as DEAN (N, N-diethylaniline). They used in-line FT-IR analysis for rapid reaction optimization and continuous aqueous work-up technologies enabled >90% recovery of the desired chloroalcohol.
Study details below – happy reading!
A convenient enantioselective CBS-reduction of arylketones in flow-microreactor systems
Sonia De Angelis,a Maddalena De Renzo,a Claudia Carlucci,a Leonardo Degennaro*a and Renzo Luisi*a
Show Affiliations Org. Biomol. Chem., 2016,14, 4304-4311
Received 11 Feb 2016, Accepted 06 Apr 2016
First published online 06 Apr 2016
About Dr. Andrew Mansfield
Andrew was formerly a Research Chemist at Pfizer and spent much of his career focusing on introducing flow chemistry technologies, meaning Andrew is well placed to lead Syrris’ flow chemistry offering. Read Andrew’s bio here.